222. Primary nephrotic syndrome Clinical trials / Disease details


Clinical trials : 310 Drugs : 295 - (DrugBank : 117) / Drug target genes : 63 - Drug target pathways : 194

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR-IPR-17011386
2017-06-012017-05-12Study on the Effect and Mechanism of Interleukin - 2 in the Treatment of Idiopathic Membranous NephropathyStudy on the Effect and Mechanism of Interleukin - 2 in the Treatment of Idiopathic Membranous Nephropathy Membranous Nephropathytreatment group:oral CsA, glucosteroid aInterleukin 2nd;Control group:oral CsA and glucosteroid;Shijiazhuang kidney disease hospital Limited companyNULLRecruiting1860Bothtreatment group:50;Control group:50;China
2ChiCTR-IPR-16008527
2016-06-012016-05-24Rituximab in the treatment of refractory membranous nephropathy: a multicenter, randomized, controlled clinical studyRituximab in the treatment of resistant membranous nephropathy: a multicenter, randomized, controlled clinical study Membranous nephropathyCsA group:oral CsA and glucosteroid;RTX group:intravenous RTX;CTX:Intravenous cyclophosphamide and glucosteroid;Ruijin Hospital, affiliated to Shanghai Jiaotong University, School of medicineNULLCompleted1870BothCsA group:60;RTX group:60;CTX:60;Phase 4China